International models among science parks

Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Countries with a clear research goal are investing in new parks, and in China, the number

Hallå där Bengt Belfrage...

... som nyligen modererade Göteborg Bios möte Biomedicinska satsningar för framtiden - några nedslag.

Novo och Astra ligger bra till i internationell kraftmätning

Patentutgångar kommer under de närmaste åren att drabba flera stora läkemedelsbolag, men Astrazeneca och Novo Nordisk hör till de som skymtar ljusglimtar enligt en analys.

Här är hela listan med de svenska ERC-miljonerna

Totalt har 236 forskare fått pengar från det europeiska forskningsrådet ERC. Tolv av dem kommer att arbeta med sina projekt i Sverige.

EU har siktet på Lundbeck

EU-kommissionen kommer att granska om den danska läkemedelsjätten har brutit mot EUs regler för konkurrens. Granskningen gäller hur Lundbeck har agerat kring generika av bolagets preparat citalopram.

Discovery of new role for leukemia gene

Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell division in several cancers.

Rapid and thorough homogenization of samples

MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.

Per Norstedt, Regional Manager, AH Diagnostics

Why are you going to Scanlab+Biotech Forum?

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. And according to her, rigorous planning is the way to succeed.

375 miljoner till cancerforskare

Cancerfonden ger Ruth Palmer pengar för forskning på signalöverföring och ett av de största anslagen går till forskning om genexpression. Även projekt inom bland annat farmakologi, cellsignalering och strålning får tillskott.

Pengar och support på önskelistan

I senaste Scanbaltrapporten identifierar organisationen fem huvudområden för att förbättra förutsättningarna inom life scienceindustrin i länderna kringa Baltikum. -Självklart siktar vi högt, säger Scanbalts generaldirektör Peter Frank.

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.

En miljard till Karolinskas groddbolag

Av runt 40 bolag tar de första klivet ut kuvösen redan i år. I skuggan av den bygg- arbetsplats som ska bli Karolinska Instiutet Science Park ligger en liten anspråkslös byggnad i gult tegel. Den ser ut som en landsortsskola från femtiotalet men inrymmer en del administration, en grupp unga företag och riskkapitalbolaget Karolinska Development.

Biovitrum sells UK part

Biovitrum will soon spin-out a British subsidary

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Swedish multi competent machine soon launched

The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.

New nanotech professor to DTU

The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.

LEO Pharma - International Clinical Trial Manager

New map of eye proteins

A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.